Skip to content

Comparison between dexmedetomidine vs dexamethasone as additive to ropivacaine(0.2%) through ultrasound guided popliteal sciatic nerve block and adductor canal block for pain management after below knee surgeries

Efficacy of dexmedetomidine and dexamethasone as adjuvants in ultrasound guided adductor canal block and popliteal sciatic nerve block for postoperative analgesia in below knee surgeries

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052981
Enrollment
98
Registered
2023-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Adductor canal block and popliteal sciatic nerve block: Group:1-Dexmedetomidine will be added to local anaesthetic in adductor canal block and popliteal sciatic nerve block. Group:2-Dex

Sponsors

DrVenkatchalam kameshwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA-1 and 2 patients posted for below knee surgeries. Consenting patients posted for elective lower limb surgeries.

Exclusion criteria

Exclusion criteria: Patient refusal History of allergy to drugs used in the study Patients on opioids for chronic pain Pregnancy History of psychiatric illness

Design outcomes

Primary

MeasureTime frame
1)Duration of analgesia (Resting VAS from0-10)(Time frame 24 hrs) 2)The time passed from block to patients first analgesic request or VAS score more than 5Timepoint: 2 years

Secondary

MeasureTime frame
To compare 24hrs opioid consumption after surgery Level of patient satisfaction Pain scores for 24 hrs at interval of 2,6,12,18 and 24 hrs Any adverse effectsTimepoint: 2 years

Countries

India

Contacts

Public ContactVenkatachalam kameshwar

Kalinga institute of medical sciences

drriteshroy@yahoo.com7008016886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026